XJPX
7634
Market cap98mUSD
Dec 05, Last price
4,900.00JPY
1D
-1.41%
1Q
3.16%
Jan 2017
32.97%
IPO
171.74%
Name
Hoshi Iryo-Sanki Co Ltd
Chart & Performance
P/E
10.43
P/S
1.01
EPS
469.70
Div Yield, %
0.82%
Shrs. gr., 5y
-0.93%
Rev. gr., 5y
6.78%
Revenues
15.10b
+2.19%
Net income
1.46b
+4.21%
CFO
2.20b
-8.22%
Dividend
Mar 30, 202645 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hoshi Iryo-Sanki Co., Ltd. manufactures and sells pharmaceutical medical oxygen and nitrous oxides in Japan. It operates in five segments: Medical Gas-Related Business; Home Healthcare-Related Business; Medical Gas Equipment Construction-Related Business; Nursing-Care Related Business; and Facilities Nursing-Related Business. The Medical Gas-Related Business segment sells medical oxygen gas, anesthetic gas, and other medical gas. The Home Healthcare-Related Business segment rents oxygen concentrators for home oxygen therapy; and equipment for continuous positive airway pressure, home ventilators, etc. The Medical Gas Equipment Construction-Related Business segment designs and constructs medical gas piping construction, as well as maintenance and inspection of medical gas piping equipment. The Nursing-Care Related Business segment offers rental and sale of nursing care related products and equipment, home renovation, home-visit nursing, and in-home nursing care support services. The Facilities Nursing-Related Business segment operates fee-based nursing homes and day care facilities, as well as related operations. The company was founded in 1960 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||